Impact of GLP-1 Receptor Agonists on Cardiovascular Risk Reduction in Patients with Type 2 Diabetes. JOC [Internet]. 2025 Nov. 2 [cited 2025 Dec. 6];24(10s):141-53. Available from: https://carcinogenesis.com/index.php/JOC/article/view/1530